Press release
Implantable Pump Catheter Market size in terms of volume and value 2018 to 2028(Based on the end-user, the market is segmented into, Ambulatory Surgical Centers Hospitals Others)
Pulmonary hypertension is a rapidly growing issue, especially among elderly population and in countries with the rise in aging population. The increasing pervasiveness of Pulmonary Arterial Hypertension (PAH) and a growing number of cases globally are driving demand for implantable pump catheter facilitating catheter implantation during treatment of PAH.
Researchers have also found Methamphetamine abuse leading to PAH. The US accounts for the maximum number of methamphetamine-related PAH patients. A significant drop in the blood stream infection is driving the demand for implantable pump catheter in PAH treatment.
Development and Testing of Several New Classes of Drugs for PAH
New drugs with vasodilator potential and other benefits including anti-smooth muscle proliferation, platelet inhibition, and improved cardiac function are being developed. Scientists at Stanley Manne Children’s Research Institute have identified a drug that inhibits HIF-2a gene. The drug targets mechanism behind PAH development. Researchers are planning to launch a clinical trial in 2019.
Along with ongoing drug formulation efforts for PAH-affected patients, recent approval by FDA for an implantable system for Remodulin, reducing the risk of complications including infection in PAH patients.
Request Free Sample Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=861
Precision Medicine Approach in Pulmonary Arterial Hypertension
Clinical outcomes and responses to PAH therapy are being modified by multiple factors, including genetic variations that are different for each person. Some recent studies have found that distinct molecular and genetic pathways in vasolidator responsive patients than non-vasoresponsive pulmonary arterial hypertension, this supports the use of the molecular technique in predicting drug responsiveness.
The treatment with calcium channel blockers is being considered a form of personalized medicine, as it is very effective in a small number of patients. Since this, no big discovery has been made in the personalized treatment of PAH. Pulmonary Arterial Hypertension behaves differently in every patient, this is driving the need for a personalized approach. The PVDOMICS initiative launched by NHLBI division aims to facilitate better treatment for PAH along with the precision medicines. Meanwhile, genetics coupled with deep molecular phenotyping is offering chances for new drug targets for PAH and possibility for more personalized medicines.
Possible System Complications can lead to Side-Effects
System complication in implantable pump catheter include tissue damage and might also lead to the damage of underlying system. The implantable pump catheter can also tear, leak or disconnect, resulting in the transfer of medication in other areas under the skin where the pump is fixed.
The risk associated with implantable pump catheter includes various symptoms of overdose and symptoms of early withdrawal. Failure of Implantable pump catheter may lead to underdose, overdose, and withdrawal which can be life-threatening. After finding that patients are being treated with medications not approved for use with implanted pumps, FDA alerted patients and healthcare providers about complications of using unapproved medications with implanted pumps.
Implantable Pump Catheter Market- Notable Developments
The US Food and Drug Administration (FDA) has approved Medtronic’s Implantable System for Remodulin. Remodulin is a drug developed by United Therapeutics that helps in treating pulmonary arterial hypertension. The recently approved system allows the whole thing to be implanted and administration of doses automatically via IV catheter.
FDA has also approved Medtronic’s new SynchroMed(TM)II myPTM(TM) Personal Therapy Manager for patients to manage chronic pain. myPTM is an app on a Samsung J3 smart device that is customized for patients to manage chronic pain.
Request/View TOC@ https://www.factmr.com/connectus/sample?flag=T&rep_id=861
Implantable Pump Catheter Market- Regional Outlook
North America is expected to hold a strong position in the implantable pump catheter market followed by Europe. US is likely to witness robust growth in the market due to the presence of well-established medical device companies, generating a majority of its sales from the US healthcare system. Japan is also expected to see healthy growth in the coming years owing to the rise in government spending on healthcare.
Implantable Pump Catheter Market Segmentation:
Based on the end-user, the market is segmented into,
Ambulatory Surgical Centers
Hospitals
Others
Extensive Analysis of Implantable Pump Catheter Market Covers:
Segmentation of implantable pump catheter market
Implantable pump catheter market dynamics
Global implantable pump catheter market size
Sales and demand in the market
Latest trends and challenges
Competition Landscape
Technological Advancements
Value chain
Regional Data Analysis of Implantable Pump Catheter Market Report Is Based On:
Implantable pump catheter market in North America (US and Canada)
Latin America implantable pump catheter market (Mexico, Argentina, and Brazil)
Implantable pump catheter market Eastern Europe (Poland, Russia, and Rest of Eastern Europe)
Western Europe implantable pump catheter market (Italy, Germany, Spain, UK, France, BENELUX, and Nordic Countries)
Asia Pacific Excluding Japan and China implantable pump catheter market (India, Australia, and New Zealand)
Implantable Pump Catheter market in Japan
China Implantable pump catheter market
Middle East and Africa implantable pump catheter market (South Africa, GCC, and Rest of MEA)
The research report on the implantable pump catheter market provides valuable insights and factors contributing to the market growth. The study also highlights trends and challenges in the implantable pump catheter market. The report provides qualitative and quantitative analysis of the market. Market segmentation and region-wise analysis of the implantable pump catheter market is offered in the report.
Important Topics in Implantable Pump Catheter Market Report are:
Outlook on parent market
Important factors in the implantable pump catheter market
Market segmentation
Market size with value and volume
Latest developments and trends
Competitive Analysis
Business strategies by market participants
Key regions with growth opportunities
Unbiased view on the implantable pump catheter market performance
Growth opportunities in the implantable pump catheter market
Report Analysis@ https://www.factmr.com/report/861/implantable-pump-catheter-market
About US
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Rohit Bhisey
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Implantable Pump Catheter Market size in terms of volume and value 2018 to 2028(Based on the end-user, the market is segmented into, Ambulatory Surgical Centers Hospitals Others) here
News-ID: 1721269 • Views: …
More Releases from Fact.MR
Allyl Polyether Market Expected to Grow at 4.5% CAGR to US$ 99.1 Million by 2033
The global Allyl Polyether Market (アリルポリエーテル市場) was valued at approximately US$ 63.8 million in 2023 and is projected to reach around US$ 99.1 million by the end of 2033, growing at a compound annual growth rate (CAGR) of 4.5%.
The Allyl Polyether Market is a segment of the polymer industry that has been witnessing steady growth in recent years. This growth can be attributed to several factors, including the increasing demand…
Construction Aggregate Market to Surge at 6.5% CAGR Through 2034
The global Construction Aggregate Market (建設骨材市場) is poised to reach US$ 418.14 billion by 2024, with a projected Compound Annual Growth Rate (CAGR) of 6.5% from 2024 to 2034. The surge in global population has fueled construction activities, leading to a substantial demand for construction aggregates. Moreover, governments in developing nations are heavily investing in infrastructure development, further boosting the demand for construction aggregates. The launch of numerous mega projects…
Chromatography Syringes Market to Experience Notable Growth by 2032
The market research and competitive intelligence company Fact.MR recently released a report estimating that sales of Chromatography Syringes would reach a valuation of US$ 140 million by 2032, growing at a compound annual growth rate (CAGR) of roughly 6% between 2022 and 2032.
Developments in chromatography syringe design and calibration, such as digitalization leading to appropriate sample pooling, are improving the performance of chromatography columns. These advancements offer benefits such faster…
Sacroiliac Joint Fusion Market: An Overview of the Forecasted CAGR of 20.2% from …
It is projected that the worldwide market for Sacroiliac Joint Fusion would be valued US$ 3,900 million by 2032, up from US$ 620 million in 2022. The market is anticipated to expand at a CAGR of 20.2% between 2022 and 2032. the rapid technological advancement in the healthcare industry and the growing demand for minimally invasive surgical treatments are responsible for the market's progress. orthopedic doctors at Yale Medicine frequently…
More Releases for Implantable
Nanotechnology in Medical Devices Market 2028 by Implantable Materials, Active I …
The Insight Partners analysts forecasts the latest report on “Global Nanotechnology in Medical Devices Market (Covid-19) Impact and Analysis by 2028”, according to report; The Nanotechnology in Medical Devices Market report covers the overall and all-inclusive analysis of Market with all its factors that have an impact on market growth. This report is anchored on the thorough qualitative and quantitative assessment of the Nanotechnology in Medical Devices Market.
The study…
Nanomedical Devices Market Highest CAGR of 10.29% by 2023 | By Types Implantable …
The Global Nano Medical Devices Market is expected to grow at a CAGR of 10.29% during Forecasted Period 2017-2023.
Nanomedical Devices Market - Segmentation
The global Nanomedical Devices Market has been segmented on the basis of applications, end users, types, and lastly region. As per application-based segmentation, this market has been segmented into disease treatment & diagnosis, drug release regulation and other. Disease treatment & diagnosis has been sub-segmented into cancer, cardiovascular…
Nanomedical Devices Market Highest CAGR of 10.29% by 2023 | By Types Implantable …
Nanomedical Devices Market - Segmentation
The global nanomedical devices market has been segmented on the basis of applications, end users, types, and lastly region. As per application-based segmentation, this market has been segmented into disease treatment & diagnosis, drug release regulation and other. Disease treatment & diagnosis has been sub-segmented into cancer, cardiovascular diseases neurological diseases, and other. With regards to end users, the market has been segmented into clinics, hospitals,…
Active Implantable Medical Devices Market (Implantable Cardioverter Defibrillato …
Global Active Implantable Medical Devices Market 2018 report includes Active Implantable Medical Devices Market Size, Revenue, market Share, Active Implantable Medical Devices industry volume, market Trends, Active Implantable Medical Devices Growth aspects. A wide range of applications, Utilization ratio, Supply and demand analysis are also consist in the report. It shows manufacturing capacity, Active Implantable Medical Devices Price during the Forecast period from 2018 to 2025.
For In depth Information Get…
Active Implantable Medical Devices Market by Product Type (Pacemaker, Implantabl …
The Global Active Implantable Medical Devices Market by product type (pacemaker, implantable cardioverter defibrillator, cardiac resynchronization therapy devices, neurostimulator, drug infusion pump, implantable loop recorder, cochlear implant, and others), and region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 16,721.2 million in 2016 and is projected to exhibit a CAGR of 5.4% over the forecast period (2017–2025), as highlighted in a new…
Implantable Cardioverter Defibrillators Contribute Largest Revenue to the Global …
According to the study, the global active implantable medical devices market is likely to grow from $17.0 billion in 2016 to $28.9 billion by 2023. Technological advancements, increasing prevalence of cardiovascular diseases, rising healthcare expenditures and increasing research and development activities have been driving the growth of the global active implantable medical devices market. The market is further expected to gain revenue due to increasing geriatric population and incidence of…
